(NYSE: AVNT) Avient's forecast annual revenue growth rate of 3.64% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.34%.
Avient's revenue in 2026 is $3,331,500,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $316,432,447,500, with the lowest AVNT revenue forecast at $300,473,245,800, and the highest AVNT revenue forecast at $331,474,453,700. On average, 12 Wall Street analysts forecast AVNT's revenue for 2027 to be $327,255,354,400, with the lowest AVNT revenue forecast at $306,159,857,900, and the highest AVNT revenue forecast at $348,075,692,250.
In 2028, AVNT is forecast to generate $341,380,165,100 in revenue, with the lowest revenue forecast at $321,385,303,200 and the highest revenue forecast at $362,017,063,850.